Skip to product information
Bioglutide (Retatrutide + Carginitide)- 10mg
€350,00
Research Use Only: All products are intended exclusively for laboratory and scientific research. Not for human or veterinary use.
Research Grade
Bioglutide (Retatrutide + Carginitide) – 10 mg
| Parameter | Value |
|---|---|
| Form | Lyophilized powder (dual-peptide blend) |
| Content | Total 10 mg per vial (Retatrutide + Carginitide); ratio not specified |
| Packaging | Glass vial with sterile closure |
| Storage | 2–8 °C (refrigerated), protect from light |
| Molecular Formula | Not specified (mixture of peptide actives) |
| Molecular Weight | Not specified (blend) |
| Test Number | BIOGLU-2501-A |
| IUPAC Name | Retatrutide (multi-incretin peptide) + Carginitide (amylin analog) |
| Other Names | Retatrutide + Cagrilintide analog; “Bioglutide” dual-peptide research blend |
Bioglutide is a dual-peptide research blend combining Retatrutide (a multi-incretin receptor agonist studied for GLP-1/GIP/glucagon pathway signaling) with Carginitide (amylin-pathway analog). In model systems it is used to explore metabolic signaling, energy balance, satiety circuitry, and glucose–lipid homeostasis through complementary incretin and amylin receptor mechanisms.
This product is not a dietary supplement, drug, or cosmetic. For laboratory research and analytical purposes only. Not for human or veterinary use.